share_log

424B2: Prospectus

SEC announcement ·  Apr 25 15:52
Summary by Moomoo AI
On April 23, 2024, JPMorgan Chase Financial Company LLC, a subsidiary of JPMorgan Chase & Co., priced $3,530,000 worth of Callable Contingent Interest Notes. These notes are linked to the performance of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index, and the S&P 500 Index, and are due on March 28, 2029. The notes offer investors the potential for a Contingent Interest Payment if each index's closing level is at or above 70% of its initial value on review dates. The notes can be redeemed early at JPMorgan's discretion on specified interest payment dates, with the earliest possible redemption date being July 26, 2024. Investors are warned of the risks, including the potential loss of principal and the possibility of receiving no Contingent Interest Payment on some...Show More
On April 23, 2024, JPMorgan Chase Financial Company LLC, a subsidiary of JPMorgan Chase & Co., priced $3,530,000 worth of Callable Contingent Interest Notes. These notes are linked to the performance of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index, and the S&P 500 Index, and are due on March 28, 2029. The notes offer investors the potential for a Contingent Interest Payment if each index's closing level is at or above 70% of its initial value on review dates. The notes can be redeemed early at JPMorgan's discretion on specified interest payment dates, with the earliest possible redemption date being July 26, 2024. Investors are warned of the risks, including the potential loss of principal and the possibility of receiving no Contingent Interest Payment on some or all review dates. The notes are unsecured and unsubordinated obligations of JPMorgan Financial, with payments fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes were priced with a minimum denomination of $1,000 and integral multiples thereof, and are expected to settle on or about April 26, 2024. The offering includes risks detailed in the prospectus supplement and the product supplement, and has not been approved or disapproved by the SEC or any state securities commission.

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more